Addressing the diversity challenge in clinical trials
Solving the challenge of increasing minority participation in clinical trials requires a long-term commitment and investment from the research community.
Read More
Search Results for: Naima Lockhart Gibson
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
